The Company has reported Q4 and full-year F2013 results, with revenue for F2013 up 14% compared with F2012. Microbix has provided updates on its thrombolytic drug Kinlytic (Urokinase) as well as announcing patent litigation against Novartis Vaccines ... 4 Traders, 1 month ago
Interim Results for the six months ended 31 December 2013 African Rainbow Minerals Limited Incorporated in the Republic of South Africa Registration number 1933/004580/06 ISIN code: ZAE000054045 INTERIM RESULTS For the six months ended 31 December ...JSE Securities Exchange, 1 day ago AFRICAN RAINBOW MINERALS LIMITED - Interim Results for the six months ended 31 December 2013 Sharenet, 1 day ago JSC: JASCO ELECTRONICS HOLDINGS LIMITED - Unaudited interim results for the six months ended 31 December 2013 JSE Securities Exchange, 2 weeks ago
The move is expected to improve competitiveness, helping US Lower 48 onshore business remain at the forefront of innovation and development of technologies for unconventional resources BP today announced its intention to establish a separate ...Noodls, 3 days ago BP PLC : BP to Form Separate Business to Manage US Lower 48 Onshore Oil and Gas Assets 4 Traders, 3 days ago BP plc : BP Agrees to Sell its Specialist Global Aviation Turbine Oils Business 4 Traders, 1 month ago
Does a Blended Learning, Flipped Classroom Pedagogy Help Information Literacy Students in the Long Term Adoption of Research Skills?
Executive Summary Research of Information Literacy and Blended Learning (BL) is in an early stage with the current body of knowledge consisting of case studies and small action based research projects. BL offers the promise of higher scores on ...LLRX.com, 5 days ago
Christoph Gisiger conducted the following interview with Howard Marks ( Trades , Portfolio ) in last week of February 2014. Christoph is from Finanz und Wirtschaft, a Swiss paper. Howard Marks ( Trades , Portfolio ) is chairman of Oaktree Capital, ...Guru Focus, 6 days ago Howard Marks: "In The End, The Devil Always Wins" Zero Hedge, 1 week ago
GlaxoSmithKline plc : GSK announces submission to U.S. regulatory authorities for Promacta (eltrombopag) for severe aplastic anaemia
GlaxoSmithKline plc (LSE:GSK) announced today the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for Promacta (eltrombopag) for the treatment of cytopenias (a reduction in blood cells) in ...4 Traders, 1 week ago GSK announces submission to U.S. regulatory authorities for Promacta? (eltrombopag) for severe aplastic anaemia Noodls, 1 week ago
ADVERTISING SPAIN & PORTUGAL Quarterly improvement adjusted by extraordinary effects 1Q (-15.2%); 2Q (-12.8%); 3Q (-4.2%); 4Q (+ 1.8%) Improvement takes place in all media segments: Press and radio in Spain and Media Capital in Portugal LATAM ...Noodls, 1 week ago PROMOTORA DE INFORMACIONES S.A. : Prisa announces results for 2013 4 Traders, 1 week ago
Net investment hedge Available-for-sale financial assets Merger reserve Equity compensation reserve Special reserve Reserve arising on Group reconstruction Total 2013 Notes £m £m £m £m £m £m £m £m £m ...TrustNet, 1 week ago
TIDMSL. RNS Number : 0469B Standard Life plc 27 February 2014 Standard Life plc Full Year Results 2013 Part 5 of 8 30. Retained earnings 2012 2013 restated(1) Notes GBPm GBPm ------------------------------------------------------- ...ADVFN UK, 1 week ago Final Results - Part 5 of 8 MoneyAM, 1 week ago
GSK kicks off 2014 Discovery Fast Track Challenge for academic drug hunters in Europe, Canada and US
PHILADELPHIA--(BUSINESS WIRE)-- GSK is inviting academic scientists to enter their most innovative drug research proposals into its 2014 a programme designed to accelerate the translation of early-stage research into game-changing new medicines. ...Yahoo! UK and Ireland, 1 week ago
More from: , 4 Traders...and 3 other sources
on your WebpageAdd Widget >Get your members hooked!